Ticker Scorecard - APLS Basics Company: Apellis Pharmaceuticals, Inc. IPO Date: November 9, 2017 Sector: Healthcare Industry: Biotech Market Cap: $3.03B Activated in VL: True Average Daily Range Avg Daily Range: $1.04 | 2.83% Avg Daily Range (30 D): $0.55 | 2.03% Avg Daily Range (90 D): $0.63 | 2.13% Institutional Daily Volume Avg Daily Volume: 1.04M Avg Daily Volume (30 D): 1.16M Avg Daily Volume (90 D): 1.66M Trade Size Avg Trade Size (Sh.): 78 Avg Trade Size (Sh.) (30 D): 66 Avg Trade Size (Sh.) (90 D): 75 Institutional Trades Total Inst.Trades: 7,223 Avg Inst. Trade: $3.28M Avg Inst. Trade (30 D): $5.16M Avg Inst. Trade (90 D): $6.9M Avg Inst. Trade Volume: .08M Avg Inst. Trades (Per Day): 4 Market Closing Trades Avg Closing Trade: $7.11M Avg Closing Trade (30 D): $9.24M Avg Closing Trade (90 D): $13.77M Avg Closing Volume: 162.77K     News Feb 24, 2025 @ 12:00 PM Apellis Pharmaceuticals to Present at the TD Cowen... Source: N/A Feb 20, 2025 @ 7:00 AM Apellis and Sobi Announce EMA Validation of Indica... Source: N/A Feb 14, 2025 @ 12:00 PM Apellis Pharmaceuticals to Host Conference Call on... Source: N/A Feb 6, 2025 @ 7:40 PM Investigation Alert: MacroGenics, Apellis Pharmace... Source: Johnson Fistel, Llp Jan 27, 2025 @ 9:00 PM Apellis Receives Approval of SYFOVRE® (pegcetac... Source: N/A Financials   TTM Q4 2024 FY 2024 Basic EPS $-1.6 $-.29 $-1.6 Diluted EPS $-1.6 $-.29 $-1.6 Revenue $ 781.37M $ 212.53M $ 781.37M Gross Profit $ $ $ Net Income / Loss $ -197.88M $ -36.35M $ -197.88M Operating Income / Loss $ -164.98M $ -26.16M $ -164.98M Cost of Revenue $ $ $ Net Cash Flow $ 60.31M $ 14.38M $ 60.31M PE Ratio     Splits Mar 19, 2004:   200:1